Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 208

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

Open access
Evgin, Laura, Kottke, Tim, Tonne, Jason, Thompson, Jill, Huff, Amanda L., van Vloten, Jacob, Moore, Madelyn, Michael, Josefine, Driscoll, Christopher, Pulido, Jose, Swanson, Eric, Kennedy, Richard, Coffey, Matt, Loghmani, Houra, Sanchez-Perez, Luis, Olivier, Gloria, Harrington, Kevin, Pandha, Hardev, Melcher, Alan, Diaz, Rosa Maria, Vile, Richard G. · 2022 · Science Translational Medicine

Abstract

Oncolytic viruses (OVs) encoding a variety of transgenes have been evaluated as therapeutic tools to increase the efficacy of chimeric antigen receptor (CAR)–modified T cells in the solid tumor microenvironment (TME). Here, using systemically delivered OVs and CAR T cells in immunocompetent mouse models, we have defined a mechanism by which OVs can potentiate CAR T cell efficacy against solid tumor models of melanoma and glioma. We show that stimulation of the native T cell receptor (TCR) with viral or virally encoded epitopes gives rise to enhanced proliferation, CAR-directed antitumor function, and distinct memory phenotypes. In vivo expansion of dual-specific (DS) CAR T cells was leveraged by in vitro preloading with oncolytic vesicular stomatitis virus (VSV) or reovirus, allowing for a further in vivo expansion and reactivation of T cells by homologous boosting. This treatment led to prolonged survival of mice with subcutaneous melanoma and intracranial glioma tumors. Human CD19 CAR T cells could also be expanded in vitro with TCR reactivity against viral or virally encoded antigens and was associated with greater CAR-directed cytokine production. Our data highlight the utility of combining OV and CAR T cell therapy and show that stimulation of the native TCR can be exploited to enhance CAR T cell activity and efficacy in mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.abn2231

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 208

Metadata

Authors
Evgin, L., Kottke, T., Tonne, J., Thompson, J., Huff, A. L., van Vloten, J., Moore, M., Michael, J., Driscoll, C., Pulido, J., Swanson, E., Kennedy, R., Coffey, M., Loghmani, H., Sanchez-Perez, L., Olivier, G., Harrington, K., Pandha, H., Melcher, A., Diaz, R. M., & Vile, R. G.
Venue
Science Translational Medicine
Published
2022-04-13
Volume
14
Issue
640
Pages
eabn2231-eabn2231
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W4224050212
Cited by
208
References
7
FWCI
14.86
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice. https://app.cochat.ai/papers/10.1126/scitranslmed.abn2231
The paper
Evgin, L., Kottke, T., Tonne, J., Thompson, J., Huff, A. L., van Vloten, J., Moore, M., Michael, J., Driscoll, C., Pulido, J., Swanson, E., Kennedy, R., Coffey, M., Loghmani, H., Sanchez-Perez, L., Olivier, G., Harrington, K., Pandha, H., Melcher, A., . . . Vile, R. G. (2022). Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abn2231

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.